CN Patent

CN103772449B — C‑芳基葡萄糖苷衍生物及其制备方法与用途

Assigned to Chang'ao Pharmaceutical Technology Holdings Ltd · Expires 2017-12-26 · 8y expired

What this patent protects

本发明公开了一种通式（I）所示的C‑芳基葡萄糖苷衍生物，其制备方法及用途，其中，R 1 、R 2 如说明书中所定义。所述的C‑芳基葡萄糖苷衍生物结构新颖，对SGLT‑2具有很强的抑制活性，同时对SGLT‑1和SGLT‑2的选择比也较高，可用于制备治疗和预防与钠依赖性葡萄糖转运蛋白相关疾病的药物。

USPTO Abstract

本发明公开了一种通式（I）所示的C‑芳基葡萄糖苷衍生物，其制备方法及用途，其中，R 1 、R 2 如说明书中所定义。所述的C‑芳基葡萄糖苷衍生物结构新颖，对SGLT‑2具有很强的抑制活性，同时对SGLT‑1和SGLT‑2的选择比也较高，可用于制备治疗和预防与钠依赖性葡萄糖转运蛋白相关疾病的药物。

Drugs covered by this patent

Patent Metadata

Patent number
CN103772449B
Jurisdiction
CN
Classification
—
Expires
2017-12-26
Drug substance claim
No
Drug product claim
No
Assignee
Chang'ao Pharmaceutical Technology Holdings Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.